Sequana Medical N.V. Logo

Sequana Medical N.V.

Develops implantable devices to treat drug-resistant fluid overload from cirrhosis and heart failure.

SEQUA | BR

Overview

Corporate Details

ISIN(s):
BE0974340722
LEI:
8755009AN12Y4PEOII07
Country:
Belgium
Address:
Kortrijksesteenweg 1112 B 102, 9051 Gent
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Sequana Medical N.V. is a commercial-stage medical device company pioneering innovative treatments for drug-resistant fluid overload. The company's lead product is the alfapump®, a proprietary, fully-implanted, and wirelessly charged system that automatically and continuously moves excess abdominal fluid (ascites) to the bladder for natural elimination. The alfapump® is the first U.S. FDA-approved active implantable device for treating recurrent or refractory ascites due to liver cirrhosis, and it also holds a CE mark in Europe. The system is designed to significantly reduce or eliminate the need for invasive therapeutic paracentesis procedures and improve patient quality of life. Sequana Medical is also developing its DSR® (Direct Sodium Removal) therapy platform to manage fluid overload in patients with heart failure.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-24 18:30
Major Shareholding Notification
2025-11-13 Transparency Notification BlackRock.pdf
English 284.9 KB
2025-11-24 18:30
Declaration of Voting Results & Voting Rights Announcements
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (24 November 20…
English 296.1 KB
2025-11-24 18:30
Major Shareholding Notification
Sequana Medical -- Transparency Notification PR BlackRock (NL) (24 November 202…
Dutch 311.7 KB
2025-11-14 18:00
Major Shareholding Notification
Sequana Medical -- Fifth GEM Subscription -- Closing PR (ENG) 14 November 2025.…
English 276.3 KB
2025-11-14 18:00
Major Shareholding Notification
Sequana Medical -- Fifth GEM Subscription -- Closing PR (NL) 14 November 2025.p…
Dutch 289.5 KB
2025-08-14 18:00
Declaration of Voting Results & Voting Rights Announcements
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (14 August 2025…
English 289.7 KB
2025-08-14 18:00
Major Shareholding Notification
Sequana Medical -- Transparency Notification PR BlackRock (NL) (14 August 2025)…
Dutch 317.1 KB
2025-08-07 18:00
Share Issue/Capital Change
20250807 Sequana Medical - GEM Subscription Notice PR (ENG).pdf
English 232.0 KB
2025-08-07 18:00
Share Issue/Capital Change
20250807 Sequana Medical - GEM Subscription Notice PR (NL).pdf
Dutch 252.2 KB
2025-07-28 18:00
Declaration of Voting Results & Voting Rights Announcements
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (28 July 2025).…
English 287.8 KB
2025-07-28 18:00
Major Shareholding Notification
Sequana Medical -- Transparency Notification PR BlackRock (NL) (28 July 2025).p…
Dutch 314.8 KB
2025-07-22 18:00
Share Issue/Capital Change
Sequana Medical - Loan Conversions -- Press Release (ENG) (22 July 2025).pdf
English 270.9 KB
2025-07-22 18:00
Share Issue/Capital Change
Sequana Medical - Loan Conversions -- Press Release (NL) (22 July 2025).pdf
Dutch 296.4 KB
2025-07-09 18:00
Declaration of Voting Results & Voting Rights Announcements
Sequana Medical -- Transparency Notification PR BlackRock (ENG) (9 July 2025).p…
English 706.3 KB
2025-07-09 18:00
Major Shareholding Notification
Sequana Medical -- Transparency Notification PR BlackRock (NL) (9 July 2025).pdf
Dutch 711.7 KB

Automate Your Workflow. Get a real-time feed of all Sequana Medical N.V. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sequana Medical N.V.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sequana Medical N.V. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2021-06-04 Fin-2K BV Executive member Buy 16,000 N/A
2021-05-27 Crosbie Ian Board Buy 32,000 N/A
2020-09-07 Fin-2K BV Executive member Buy 20,036 N/A
2020-09-04 Crosbie Ian Board Buy 40,073 N/A
2019-06-06 wim ottevaere Board Buy 4,000 25,600.00 EUR
2019-03-29 Fin-2K BV Executive member Buy 20,383 N/A
2019-03-06 Crosbie Ian Board Buy 40,766 N/A
2019-02-26 Chauvineau Pierre Board Buy 10,192 N/A
2019-02-13 wim ottevaere Board Buy 7,000 49,345.10 EUR

Peer Companies

FRANCE BED HOLDINGS CO.,LTD. Logo
Makes, sells, and rents medical beds and home furnishings for Japan's aging population.
Japan
7840
Fresenius SE & Co. KGaA Logo
Provides critical biopharma, medtech, and hospital care for critically & chronically ill patients.
Germany
FRE
FUJI SEIKO LIMITED Logo
Manufactures precision metal tubing & cannula for global medical device makers.
Japan
6142
GENEDRIVE PLC Logo
Develops rapid, point-of-care genetic tests for time-critical healthcare to personalize medicine.
United Kingdom
GDR
Gerresheimer AG Logo
Global provider of packaging and drug delivery systems for pharma, biotech, and cosmetics.
Germany
GXI
Getinge Logo
Provides medical tech for healthcare & life sciences, with systems for ICU, ORs & sterile processing.
Sweden
GETI
GLAUKOS Corp Logo
Develops ophthalmic therapies and devices for glaucoma, corneal, and retinal diseases.
United States of America
GKOS
GLOBUS MEDICAL INC Logo
Develops musculoskeletal solutions for spine surgery, trauma, and orthopedics.
United States of America
GMED
Glucotrack, Inc. Logo
Developing a long-term, implantable glucose monitor for diabetes management.
United States of America
GCTK
Glycorex Transplantation AB Logo
Develops devices that remove blood antibodies, enabling organ transplants across blood groups.
Sweden
GTAB

Talk to a Data Expert

Have a question? We'll get back to you promptly.